Skip navigation
Please use this identifier to cite or link to this item:
Title: Macroloides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
Authors: Bermejo-Martín, Jesús F.
Kelvin, David J.
Eiros Bouza, José María
Castrodeza, Javier
Ortiz de Lejarazu y Leonardo, Raúl
Issue Date: 2009
Description: Producción Científica
Citation: Journal of Infection Developing Countries 2009; 3(3):159-161.
Abstract: The current outburst of a new H1N1 swine influenza strain(s) in México and the United States is causing great concern in health authorities and in the general population [1]. With the World Health Organization (WHO) reporting the pandemic potential of the new strain, it is necessary to determine which therapeutic options are available until a specific vaccine is available. Based on information from the Centre for Disease Control (CDC), the virus is sensitive to oseltamivir and zanamivir. Antivirals are strongly affected by viral mutations; thus their efficiency could be lost as the virus changes.
Keywords: Gripe - Vacunas
ISSN: 1972-2680
Peer Review: SI
DOI: 10.3855/jidc.18
Language: eng
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:DEP03 - Artículos de revista

Files in This Item:
File Description SizeFormat 
PD-266.pdfPD-266151,38 kBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons

University of Valladolid
Powered by MIT's. DSpace software, Version 5.5